Oklahoma City
Pure MHC focuses on HLA related immunology tools for vaccine development and immunotherapy validation.

Oklahoma City
Heparinex is a biotechnology company focused on the development of novel recombinant synthesis of...

Oklahoma City
Charlesson is an ocular pharmaceutical company that is developing therapeutics for various eye di...

Sapulpa
Kemmx Corporation is a start-up, biotechnology company pioneering the development and commerciali...

Oklahoma City
Choncept?s scientific innovation is focused on development of new technology to produce chondroit...

Oklahoma City
DormaTarg, Inc is a biotechnology company researching and developing therapeutic drugs for cancer...

Oklahoma City
Anastasia Marie Labs, Inc. specializes in over-the-counter diabetic skin treatment products.

Oklahoma City
Tetherex is developing a treatment for inflammatory and thrombotic diseases such as Crohn’s...

Oklahoma City
Jortan Pharmaceuticals Inc.?(JORTAN) was founded around aspartic protease inhibitors as potential...

Oklahoma City
EpimedX, LLC is a biotechnology company that was founded in 2011 with the mission to develop Gene...

Oklahoma City
COARE Biotechnology is a research driven pharmaceutical company dedicated to developing novel the...

Oklahoma City
Analytical testing laboratory that provides innovative methodologies for greater flexibility and ...

Oklahoma City
The Lupus Multiplex Registry and Repository is finding the genes that cause lupus (also known as ...

Oklahoma City
Hyalose specializes in Hyaluronic Acid production and application. The Emergent Technologies Inc....

Oklahoma City
PreDENT has developed a vaccine to help prevent gingivitis and periodontal disease in pets?that p...

Edmond
Leviathan proposes a next-generation tool that will make it possible to distinguish and examine h...

Oklahoma City
Selexys is a development stage biopharmaceutical company focused on the treatment of inflammatory...

Oklahoma City
Cytovance? Biologics adds significant value to biopharmaceutical development programs assisting c...

Oklahoma City
Biolytx Pharmaceuticals develops a novel antibiotic peptide for use in treatment of serious hospi...

Stillwater
Respiron is developing an antiviral drug, RN-1, to treat any existing and emerging strains of inf...

Oklahoma City
Synereca Pharmaceuticals addresses the growing problem of bacterial resistance to current antibio...